Skip to content

Evaluation of Emotion-related Salivary Molecular Biomarkers

Evaluation of Emotion-related Salivary Molecular Biomarkers Following Olfactory Stimuli

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07320040
Acronym
EMJOY
Enrollment
240
Registered
2026-01-06
Start date
2022-11-14
Completion date
2027-06-14
Last updated
2026-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emotion

Keywords

Biomarkers, Stimuli, Related

Brief summary

Recent studies show that emotional states can be discriminated by physiological responses. This physiological regulation results from the action of enzymes and hormones that represent the activity of the autonomic nervous system. The measurement of specific biomarkers, using non-invasive biological tests in saliva, would therefore provide physiological data on an individual's emotional state in response to stimuli, particularly olfactory stimuli.

Detailed description

Recent studies show that emotional states (positive and negative) can be discriminated by physiological responses. This physiological regulation stems from the action of enzymes and hormones that represent the activity of the autonomic nervous system. The measurement of specific biomarkers (enzymes, hormones), using non-invasive biological tests in saliva, would therefore provide physiological data on an individual's emotional state (Giacomello et al. 2020) in response to stimuli, particularly olfactory stimuli. The aim of the proposed research is to identify and measure a signature of molecular biomarkers in saliva, linked to emotions following one or more olfactory stimuli (e.g. cortisol and alpha-amylase concentration increase after stimulation).

Interventions

OTHERIdentication and measurement of a molecular biomarkers signature

Levels of the biomarkers of interest (DHEA, pg/mL; Oxytocin, pg/mL; Cortisol, pg/mL; Alpha Amylase, U/mL) will be measured in the saliva of participating subjects by enzymatic assay methods or ELISA-type methods performed using commercial kits.

Sponsors

Sys2Diag
Lead SponsorOTHER_GOV
Centre National de la Recherche Scientifique, France
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Subject willing to follow study procedures * Subject able to understand the purpose, nature and methodology of the study * Subject has signed informed consent form * Subjects between 18 and 60 years of age.

Exclusion criteria

* Subjects deprived of liberty, protected adults, vulnerable persons or minors * Subjects with a proven or suspected chronic infectious disease that could entail a risk of contamination during sample handling (laboratories not equipped to handle this type of sample) * Rejection to sign the consent form. Non specific inclusion criteria: * Pregnant or breastfeeding women * Subjects presenting anosmia during the last 15 days * Subjects presenting symptoms and signs of active oral inflammation, advanced periodontitis or severe gingivitis.

Design outcomes

Primary

MeasureTime frameDescription
Evaluate variations1 yearEvaluate variations in several molecular biomarkers in saliva following fragrance stimulus/stimuli that may be linked to an emotionnal response (positive or negative).

Secondary

MeasureTime frameDescription
Identify a molecular biomarker signature2 yearsIdentify a molecular biomarker signature in saliva following fragrance stimulus or stimuli.
Evaluate basal values of biomarkers3 yearsEvaluate basal values of biomarkers composing the signature under normal, unstimulated conditions (intra-individual, inter-individual variations, circadian rhythm, age, gender...).
Evaluate signature dynamics1 yearEvaluate signature dynamics after stimulation
Establish correlations between biomarker signatures and emotion ratings3 yearsEstablish correlations between biomarker signatures and emotion ratings based on other criteria, such as questionnaires.
Compare biomarker signatures2 yearsCompare biomarker signatures in response to different fragrance stimuli.

Countries

France

Contacts

CONTACTWendpouiré A OUEDRAOGO, Msc
alimata.ouedraogo@sys2diag.cnrs.fr+33 (0) 467 047 481
PRINCIPAL_INVESTIGATORLaurence MOLINA, Phd

Sys2Diag

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026